| For: | Shi YF, Lu JG, Yang QM, Duan J, Lei YM, Zhao W, Liu YQ. Primary hepatoid adenocarcinoma of the lung in Yungui Plateau, China: A case report. World J Clin Cases 2019; 7(13): 1711-1716 [PMID: 31367631 DOI: 10.12998/wjcc.v7.i13.1711] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v7/i13/1711.htm |
| Number | Citing Articles |
| 1 |
Wenting Wang, Guang Li. <p>Radiotherapy of Pulmonary Hepatoid Adenocarcinoma with Intrahepatic Hemangioma: A Case Report</p>. OncoTargets and Therapy 2020; doi: 10.2147/OTT.S275340
|
| 2 |
Yongxun Zhuansun, Lijuan Bian, Zhuxiang Zhao, Yumo Du, Rui Chen, Lin Lin, Jianguo Li. Clinical characteristics of Hepatoid adenocarcinoma of the lung: Four case reports and literature review. Cancer Treatment and Research Communications 2021; 29 doi: 10.1016/j.ctarc.2021.100474
|
| 3 |
Zhitao Chen, Chenchen Ding, Ting Zhang, Yahui He, Guoping Jiang. Primary Hepatoid Adenocarcinoma of the Lung: A Systematic Literature Review. OncoTargets and Therapy 2022; doi: 10.2147/OTT.S364465
|
| 4 |
Huijing Deng, Luyao Wang, Zewei Li, Tao Zhan, Liu Huang. Optimal treatment strategies for hepatoid adenocarcinoma of the lung: insights from a comprehensive analysis. BMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-12682-z
|
| 5 |
Chengsen Cai, Ningxin Zhang, Min Wang, Lianzhong Wang, Haisu Zhao, Xiaoye Zhang, Bin Li, Jun Wang. Primary hepatoid adenocarcinoma of the lung with extremely elevated serum AFP: a case report and literature review. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1448219
|
| 6 |
Alessandro Bonis, Andrea Dell’Amore, Vincenzo Verzeletti, Luca Melan, Giovanni Zambello, Chiara Nardocci, Giovanni Maria Comacchio, Federica Pezzuto, Fiorella Calabrese, Federico Rea. Hepatoid Adenocarcinoma of the Lung: A Review of the Most Updated Literature and a Presentation of Three Cases. Journal of Clinical Medicine 2023; 12(4) doi: 10.3390/jcm12041411
|
| 7 |
Hui Sun, Xiaoli Li, Jianguo Zhang, Yifei Liu. Clinicopathological features and genomic profiles of hepatoid adenocarcinoma of the lung: Report of four cases. Pathology - Research and Practice 2022; 229 doi: 10.1016/j.prp.2021.153652
|
| 8 |
Kun Xu, Jin Gao, Lili Feng, Ying Fang, Xiuliang Tang. A case report of pulmonary hepatoid adenocarcinoma: promoting standardized diagnosis and treatment of the rare disease. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1203876
|
| 9 |
Jing Feng, Yongsheng Wang, Fan Li, Yanmei Wen, Wenhao Xu, Xiaobo Hu. Hepatoid adenocarcinoma of the lung with normal serum alpha-fetoprotein managed with thoracic radiotherapy followed by tislelizumab plus lenvatinib: a case report and systematic review. Frontiers in Oncology 2026; 16 doi: 10.3389/fonc.2026.1963662
|
| 10 |
Zan Hou, Jiaqing Xie, Li Zhang, Gangyi Dai, Yuanhang Chen, Lang He. Hepatoid Adenocarcinoma of the Lung: A Systematic Review of the Literature From 1981 to 2020. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.702216
|
| 11 |
Yao Yao, Xiaojiao Guan, Guangyao Bao, Jie Liang, Tian Li, Xinwen Zhong. Whole-exome sequencing and bioinformatics analysis of a case of non-alpha-fetoprotein-elevated lung hepatoid adenocarcinoma. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.945038
|